Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Heron Therapeutics (HRTX) Interest Coverage Ratio: 2012-2016

Historic Interest Coverage Ratio for Heron Therapeutics (HRTX) over the last 1 years, with Dec 2016 value amounting to -63.56.

  • Heron Therapeutics' Interest Coverage Ratio was N/A to -63.56 in Q4 2016 from the same period last year, while for Dec 2016 it was -64.13, marking a year-over-year change of. This contributed to the annual value of -1.91 for FY2024, which is 93.32% up from last year.
  • Heron Therapeutics' Interest Coverage Ratio amounted to -63.56 in Q4 2016, which was down 4.89% from -60.59 recorded in Q3 2013.
  • Heron Therapeutics' Interest Coverage Ratio's 5-year high stood at -23.61 during Q1 2012, with a 5-year trough of -74.19 in Q2 2013.
  • Its 1-year average for Interest Coverage Ratio is -63.56, with a median of -63.56 in 2016.
  • Data for Heron Therapeutics' Interest Coverage Ratio shows a maximum YoY plummeted of 168.72% (in 2013) over the last 5 years.
  • Quarterly analysis of 3 years shows Heron Therapeutics' Interest Coverage Ratio stood at -23.61 in 2012, then plummeted by 168.72% to -60.59 in 2013, then reached -63.56 in 2016.
  • Its last three reported values are -63.56 in Q4 2016, -60.59 for Q3 2013, and -74.19 during Q2 2013.